AbbVie Inc (NYSE:ABBV) announced financial results for the third quarter ended September 30, 2016. “We delivered another strong quarter, with EPS growth ahead …
AbbVie Inc (NYSE:ABBV) announced financial results for the second quarter ended June 30, 2016. “AbbVie continues to deliver on our long-term strategy, as demonstrated …
By Dirk S. Leach Today, long term investors are challenged in navigating the course and lining up that long drive for a investment …
At an R&D Day meeting today for the investment community, AbbVie Inc (NYSE:ABBV), a global biopharmaceutical company, will present an overview of its innovative …
AbbVie Inc (NYSE:ABBV) announced financial results for the first quarter ended March 31, 2016. “AbbVie delivered strong first-quarter results, including significant revenue and EPS …
AbbVie Inc (NYSE:ABBV) announced financial results for the fourth quarter and full year ended Dec. 31, 2015.
AbbVie Inc (NYSE:ABBV) is an interesting business – it has the highest qualitative risk of any Dividend Aristocrat. Risk and Dividend Aristocrats typically …
Evercore ISI analyst Mark Schoenebaum weighed in today with his views on AbbVie Inc (NYSE:ABBV), as the company is scheduled to report its second-quarter earnings results on Friday, …
Dividend Aristocrats are popular on the market because they have achieved to hike dividends over more than 25 years. A rising income is an …
This Weekend my eyes and thoughts curved around the Healthcare sector. I read several interesting articles from the sector, mostly about the biotech’s …
